Filtered By:
Condition: Atrial Fibrillation
Countries: Japan Health
This page shows you your search results in order of relevance. This is page number 13.
Order by Relevance | Date
Total 333 results found since Jan 2013.
Extent of Late Gadolinium Enhancement Predicts Thromboembolic Events in Patients With Hypertrophic Cardiomyopathy.
CONCLUSIONS: LGE extent (>14.4%) is an independent predictor for thromboembolic complications in patients with HCM and might therefore be considered as an important risk marker. The risk for thromboembolic events is significantly elevated if accompanied by AF.
PMID: 32238665 [PubMed - as supplied by publisher]
Source: Circulation Journal - March 31, 2020 Category: Cardiology Authors: Hohneck A, Overhoff D, Doesch C, Sandberg R, Rudic B, Tueluemen E, Budjan J, Szabo K, Borggrefe M, Papavassiliu T Tags: Circ J Source Type: research
Clinical outcomes of ablation versus non-ablation therapy for atrial fibrillation in Japan: analysis of pooled data from the AF Frontier Ablation Registry and SAKURA AF Registry
AbstractWhether ablation for atrial fibrillation (AF) is, in terms of clinical outcomes, beneficial for Japanese patients has not been clarified. Drawing data from 2 Japanese AF registries (AF Frontier Ablation Registry and SAKURA AF Registry), we compared the incidence of clinically relevant events (CREs), including stroke/transient ischemic attack (TIA), major bleeding, cardiovascular events, and death, between patients who underwent ablation (n = 3451) and those who did not (n = 2930). We also compared propensity-score matched patients (n = 1414 in each group). In propensity-scored patients who underwent abl...
Source: Heart and Vessels - November 24, 2020 Category: Cardiology Source Type: research
Clinical outcomes according to dose reduction criteria of apixaban in Japanese elderly patients with atrial fibrillation: J-ELD AF Registry subanalysis
AbstractDose reduction of apixaban is applied in atrial fibrillation (AF) patients fulfilling ≥ 2 of the following criteria: (1) age ≥ 80 years, (2) body weight ≤ 60 kg and (3) serum creatinine ≥ 1.5 mg/dL. However, the clinical significance of each criterion remains unclear. The J-ELD AF Registry is a prospective observational study of elderly (≥ 75 years) J apanese AF patients receiving on-label dose of apixaban. In patients receiving the standard dose (5 mg bid,n = 1243), the incidence rates (% per patient-year) of stroke or systemic embolism in those fulfilling none [n = 516] o...
Source: Heart and Vessels - January 24, 2021 Category: Cardiology Source Type: research
Basilar artery occlusion presenting as sudden bilateral deafness: a case report
ConclusionsWhen hearing loss is due to vertebrobasilar occlusive disease, the prognosis is very poor. We suggest that vertebrobasilar stroke be suspected in patients with bilateral sensorineural hearing loss who present with risk factors for stroke such as atrial fibrillation and other neurologic signs.
Source: Journal of Medical Case Reports - March 2, 2021 Category: General Medicine Source Type: research
Additional Effects of Antiplatelet Therapy on Anticoagulant Agents in Patients With Bioprosthetic Valves and Atrial Fibrillation
CONCLUSIONS: Additional SAPT on anticoagulant therapy in patients with bioprosthetic valves and AF was associated with a reduction in stroke/systemic embolic events, although the cumulative incidence of bleeding was similar, regardless of additional SAPT. These findings suggest that additional SAPT on anticoagulant therapy may be safe and effective in real-world clinical settings.PMID:34853280 | DOI:10.1253/circj.CJ-21-0716
Source: Circulation Journal - December 2, 2021 Category: Cardiology Authors: Masashi Amano Makoto Miyake Takeshi Kitai Yuki Obayashi Misa Takegami Kunihiro Nishimura Yutaka Furukawa Chisato Izumi Source Type: research
Association of C-reactive Protein with Cardiovascular Outcomes: A Mendelian Randomization Study in the Japanese Population
CONCLUSIONS: Suggestive evidence was found only in analysis of congestive heart failure; therefore, further studies are necessary. Furthermore, no causal association was found between CRP and the other three cardiovascular outcomes.PMID:35197177 | DOI:10.3967/bes2022.017
Source: Biomedical and Environmental Sciences : BES - February 24, 2022 Category: Biomedical Science Authors: Ming Yang Cao Di Liu Xiao Yu Zhang Qiu Yue Tian Qun Zhang You Xin Wang Source Type: research
